Lifecore Biomedical, Inc. LFCR

4.20 (0.09) (2.10%) as of 25 Sep
Market cap
$162.4M
P/E
0.0×
Growth Flags show if company had growth for consecutive years
May '16 May '17 May '18 May '19 May '20 May '21 May '22 May '23 May '24 May '25
P/E ratio
0.00 35.77 15.62 781.10 0.00 0.00 0.00 0.00 14.75 0.00
P/S ratio
0.66 0.81 0.74 0.50 1.97 3.38 2.52 2.38 1.39 1.85
P/FCF ratio
0.00 49.47 0.00 0.00 0.00 12.14 0.00 0.00 0.00 0.00
P/Operating CF
21.85 57.36 (745.19) (196.87) (24.89) 58.08 (510.82) (108.47) 20.42 44.74
P/B ratio
1.47 1.67 1.54 1.04 1.37 1.68 3.09 0.00 15.73 179.05
Price to Tangible BV
2.22 2.54 2.20 1.90 2.56 2.38 3.88 0.00 0.00 0.00
EV/Sales
0.76 0.92 0.87 0.77 3.16 5.29 3.84 3.80 2.49 2.97
EV/EBITDA
0.00 15.07 15.63 15.80 40.66 25.57 6.97 308.09 39.86 0.00
EV/Operating CF
15.81 12.17 17.55 20.61 (15.83) 15.28 (15.88) (18.80) (47.08) (74.55)
EV/FCF
(11.52) 55.76 (27.38) (10.16) (7.01) 19.00 (6.32) (8.46) (9.26) (30.80)
Quick Ratio
1.00 1.01 0.64 0.52 0.47 0.42 0.22 1.22 0.91 1.22
Current Ratio
1.53 1.58 1.10 0.97 0.96 1.46 0.66 2.39 2.08 2.84
Net Debt/EBITDA
(4.56) 1.89 2.69 7.14 32.11 17.45 1.74 (20.15) (158.92) (15.59)
Debt/Assets
17.85% 15.05% 18.02% 28.70% 35.16% 38.55% 53.93% 65.69% 59.02% 63.50%
Debt/Equity
0.29 0.24 0.29 0.55 0.82 0.96 1.69 4.75 2.78 3.20
Asset Turnover
1.38 1.34 1.37 1.21 0.30 0.19 0.29 0.39 0.51 0.52
Operating CF/Net income
(1.78) 2.82 0.80 38.98 0.45 (0.51) 0.19 0.18 0.02 0.00
Capex/Depreciation
(4.21) (2.15) (2.70) (2.92) (0.76) (0.62) (0.30) (1.48) (2.31) (0.80)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
(5.38%) 4.81% 10.33% 0.16% (15.24%) (14.89%) (80.32%) (238.21%) 339.11% (701.27%)
ROA
(3.38%) 3.02% 6.51% 0.09% (7.20%) (6.19%) (30.02%) (37.70%) 4.73% (17.98%)
ROIC
(4.89%) 3.32% 2.63% 0.82% (3.84%) (1.39%) (3.14%) (7.46%) (2.83%) (5.64%)
Return on Tangible Assets
(7.72%) 6.50% 14.75% 0.21% (20.64%) (19.37%) (198.64%) (52.69%) 6.28% (24.04%)
Average Days of Receivables
35.52 35.66 37.51 45.54 173.77 149.91 125.68 102.58 77.07 81.26
Research and Development Expense of Revenue
1.52% 2.02% 2.44% 2.06% 4.74% 6.63% 7.05% 8.46% 6.69% 6.41%
Selling, General and Administrative Expense of Revenue
9.68% 11.17% 9.91% 11.13% 25.41% 27.48% 31.15% 37.74% 31.55% 34.18%
Intangible Assets out of Total Assets
0.21 0.22 0.19 0.24 0.20 0.12 0.07 0.07 0.07 0.08
Share Based Compensation of Revenue
0.73% 0.84% 0.84% 0.64% 1.51% 3.33% 2.34% 3.50% 4.83% 7.88%
Graham Net Nets
(0.14) (0.13) (0.14) (0.41) (0.48) (0.45) (0.23) (0.51) (0.67) (0.44)
Graham Number
0.00 8.58 13.65 1.65 0.00 0.00 0.00 3.19 1.82 0.00
Earnings Yield
(3.72%) 2.80% 6.40% 0.13% (12.09%) (9.60%) (34.85%) (39.04%) 6.78% (16.30%)
Free Cash Flow Yield
(10.10%) 2.02% (4.31%) (15.01%) (22.84%) 8.24% (24.16%) (18.93%) (19.38%) (5.21%)
Revenue per Share
17.63 17.22 19.04 19.66 5.49 3.44 3.78 3.45 4.21 3.70
Operating CF per Share
0.77 1.09 0.72 0.56 (0.58) 0.56 (0.77) (0.58) 0.01 (0.01)
Capex per Share
(1.46) (0.84) (1.22) (1.57) (0.83) (0.42) (0.98) (0.72) (0.60) (0.18)
Free Cash Flow per Share
(0.70) 0.25 (0.50) (1.00) (1.42) 0.14 (1.74) (1.30) (0.60) (0.19)
Cash per Share
0.37 0.22 0.11 0.04 0.01 0.04 0.03 0.64 0.28 0.24
Shareholders Equity per Share
7.85 8.36 9.17 9.53 7.92 6.92 2.98 1.17 1.77 1.36
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
7.85 8.36 9.17 9.53 7.92 6.92 2.98 1.17 1.77 1.36
Free Cash Flow
(18.81) 6.92 (13.71) (28.45) (41.29) 4.16 (51.39) (38.92) (18.14) (6.62)
Working Capital
29.96 29.83 8.69 (4.05) (7.28) 46.43 (59.91) 54.59 42.16 55.50
Capital Expenditures
(39.57) (22.92) (33.49) (44.47) (24.25) (12.31) (28.80) (21.48) (18.39) (6.41)
Net Current Asset Value
(44.00) (49.18) (55.08) (115.91) (153.16) (151.82) (70.21) (124.58) (119.02) (106.23)
EV/EBIT
0.00 29.34 33.73 78.40 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.08 0.05 0.06 0.08 0.15 0.12 0.26 0.21 0.14 0.05
Net Profit Margin
(2.44%) 2.25% 4.74% 0.07% (23.86%) (32.01%) (104.89%) (96.41%) 9.37% (34.42%)
Price to Operating Income
0.00 26.03 28.57 51.38 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.08 0.08 0.08 0.08 0.17 0.17 0.81 0.11 0.05 0.06
Cash ROIC
(35.33%) (35.88%) (42.58%) (43.79%) (49.65%) (26.09%) (59.61%) (68.79%) (70.15%) (62.21%)
Accounts Receivable Turnover
10.27 10.18 10.51 9.03 2.20 1.72 2.79 3.07 4.57 4.62
Accounts Payable Turnover
12.44 14.09 15.07 10.75 2.29 1.82 4.94 4.30 4.50 7.21
Inventory Turnover
16.22 15.89 16.09 11.09 2.00 0.96 1.46 1.96 2.14 2.45
Average Days of Payables
27.50 22.92 28.38 41.34 156.21 96.05 65.47 107.13 68.99 33.88
Days of Inventory on Hand
22.72 22.07 26.05 41.46 200.56 371.71 181.98 198.01 168.87 133.07
Average Receivables
46.44 46.15 49.89 61.72 72.89 58.82 39.87 33.67 28.05 27.89
Average Payables
32.96 27.72 29.60 44.32 52.81 33.97 14.63 17.52 19.22 12.28
Average Inventory
25.28 24.58 27.72 42.98 60.22 64.69 49.54 38.42 40.41 36.14
Average Assets
344.56 350.63 381.66 461.90 530.20 522.12 388.81 264.12 253.75 246.65
Average Common Equity
216.23 220.25 240.36 261.35 250.59 216.91 145.30 41.80 3.54 6.33

Fold the line items

Columns are period end dates